skip to navigation
skip to content
Search
About us
Who we are
Horizon scanning
Public involvement
Policies & publications
Latest updates
Minutes
Meetings
Register for a meeting
Contact us
Medicines advice
How we decide
PACE
Interim acceptance decision option
Ultra-orphan medicines for extremely rare conditions
Making a submission
Medicines advice
Home
/
Medicines advice
Search Filters
Know what are you looking for?
Submission type
Please choose
Abbreviated
Full
IRP
Non submission
Resubmission
Ultra-orphan initial assessment
British National Formulary - Chapter
Please choose
Gastro-intestinal system
Cardiovascular system
Respiratory system
Central nervous system
Infections
Endocrine system
Obstetrics, gynaecology, and urinary-tract disorders
Malignant disease and immunosuppression
Nutrition and blood
Musculoskeletal and joint diseases
Eye
Ear, nose and oropharynx
Skin
Immunological products and vaccines
Anaesthesia
Pharmaceutical company
Please choose
3M Healthcare Ltd
A Menarini Pharmaceuticals UK Ltd
Abbott Healthcare Products Ltd
Abbott Laboratories
Abbott Laboratories Limited
AbbVie Ltd
Abraxis Bioscience Ltd
Accord Healthcare
Actavis
Actelion Pharmaceuticals UK Ltd
Adelphi Values
Adienne
Advanced Accelerator Applications
Akcea Therapeutics UK Ltd
Alcon Eye Care UK Ltd
Alcon Laboratories UK Ltd
Alexion Pharma UK Ltd
Alimera Sciences
ALK-Abello Ltd
Allergan Ltd
Allergan/Actavis
Alliance Pharma
Almirall Ltd
Alnylam Pharmaceuticals
Altana Pharma Ltd
Amdipharm PLC
Amgen Ltd
Amicus
Amring Pharma
Archimedes Pharma UK Ltd
Ardana Bioscience
ARIAD Pharmaceuticals Europe SARL
Aspire Pharma Ltd
Astellas Pharma Ltd
AstraZeneca UK Ltd
Aventis
B Braun Medical Ltd
Basilea Pharmaceuticals Ltd
Bausch and Lomb GmbH
Baxalta
Bayer Plc
Bayer plc/Bayer Schering Pharma
Besins Healthcare (UK) Ltd
Bial Pharma UK Ltd
BIOCODEX
Bioenvision Limited
Biofrontera Bioscience GmbH
Biogen Idec Ltd
Biolitec Pharma Ltd
BioMarin
Biotech / Adelphi Values
Boehringer Ingelheim Ltd
Brancaster Pharma Limited
Bristol-Myers Squibb Pharmaceuticals Ltd
Bristol-Myers Squibb Pharmaceuticals Ltd / AstraZeneca
Cambridge Laboratories
Camurus Ltd
Cardiome UK Limited
Celgene Ltd
Celltech
Celltrion Healthcare Hungary Kft
Cephalon UK Ltd
Chiesi Limited
Chiesi Pharmaceuticals/Trinity Pharmaceuticals
Chiron Biopharmaceuticals
Chugai Pharma UK Ltd
Clinigen Healthcare Ltd
Clinuvel (UK) Ltd
Clovis Oncology UK Limited
Consilient Health Ltd
CSL Behring
CTI Life Sciences Ltd
Cubist (UK) Limited
Daiichi Sankyo UK Ltd
Diurnal Limited
Dompe UK Ltd
Dr Falk Pharma UK
Edmond Pharma Sr.I/Galen Ltd
Eisai Ltd
Elan Pharmaceuticals
Eli Lilly and Company Ltd
Encysive (UK) Ltd
EUSA Pharma (Europe) Limited
EusaPharma
Evolan Pharma AB
Ferring Pharmaceuticals Ltd
FINOX Biotech
Flynn Pharma Ltd
Fresenius Medical Care (UK) Ltd
Fujisawa
Galderma (UK) Ltd
Galen Ltd
Gedeon Richter UK Ltd
Genentech
Genus Pharmaceuticals
Genzyme Therapeutics Ltd
Gilead Sciences Ltd
GlaxoSmithKline UK Ltd
GMP-Orphan United Kingdom Ltd
Goldshield Pharmaceuticals Limited
Grifols UK Ltd
Grünenthal Ltd
GW Pharmaceuticals Ltd
HFA Healthcare Ltd
Holostem Terapie Avanzate srl
Horizon Pharma
Hospira UK Limited
HRA Pharma UK Ltd
Immedica
Indivior UK Limited
Insmed
Integ Health/Special Products Ltd
Intercept Pharmaceuticals
Intermune UK Ltd
Internis Pharmaceuticals Ltd
Intrapharm Laboratories Ltd
Ipsen Ltd
Janssen-Cilag Ltd
Javelin Pharmaceuticals UK Ltd
Jazz Pharmaceuticals
Jerini AG
John Wyeth and Brother Limited
Kite Pharma, a Gilead Company
Kora Healthcare
Kyowa Kirin
L Molteni and Co
Laboratoire HRA Pharma
Leadiant Biosciences
LEO Pharmaceuticals
Ligland/Elan
Lilly UK
Lincoln Medical Limited
Link Pharmaceuticals Ltd
LIPOMED GmbH
Lucane Pharma
Lundbeck Ltd
Lupin Healthcare
Malborough Pharmaceuticals Ltd
Martindale Pharma
Meda Pharmaceuticals Ltd
Medac Pharma LLP
Medac Pharmaceuticals
Medac UK
Medtronic
Menarini Pharmaceuticals UK
Merck
Merck KGaA
Merck Serono Europe Limited / Pfizer Limited
Merck Serono Ltd
Merck Sharp & Dohme Ltd
Mercury Pharmaceuticals Ltd
Merz Pharma UK Ltd
Mitsubishi Pharma Europe Ltd
Movetis UK
Movetis UK Regus
MSD
MSD Limited / Pfizer Limited
MSD/Schering Plough
Napp Pharmaceuticals Ltd
Neoceuticals Ltd
New company
Nordic Pharma UK
Norgine Ltd
Nova Laboratories Ltd
Novartis Gene Therapies
Novartis Pharmaceuticals UK Ltd
Novo Nordisk Ltd
NPS Pharma UK Ltd
Nycomed UK Ltd
Omacor
Orexigen Therapeutics Ireland Limited (1)
Organon Laboratories Ltd
Orion Pharma (UK) Ltd
Orphan Europe (UK) Ltd
Ortho Biotech
Otsuka Pharmaceutical Europe
Pan Quimica Farmaceutica S.A.
Pfizer Ltd
Pfizer/Bristol Myers Squbb
Pharma Mar S.A.
Pharmacia
Pharmacosmos UK
Pharmasure Ltd
Pharmaxis Pharmaceuticals Ltd
Pharming Group NV
Pierre Fabre Ltd
Portola Pharmaceuticals UK Ltd
PregLem UK
Procter and Gamble
Profile Pharma Ltd
ProStrakan
Proveca Limited
PTC Therapeutics
Qdem Pharmaceuticals
Ranbaxy (UK) Ltd
Raptor Pharmaceuticals
Ratiopharm UK
Recordati Pharmaceuticals
Roche
Roche/GSK
Sandoz Ltd
Sankyo Pharma UK Ltd
Sanofi
Sanofi Genzyme
Sanofi-Aventis
Santen
Santhera Pharmaceuticals
Schering Health Care Ltd
Schering-Plough Ltd
Schwarz Pharma Ltd
Scope Ophthalmics Ltd
Serono Ltd
Servier Laboratories Ltd
Shield Therapeutics
Shionogi Limited
Shire Pharmaceuticals
Shire-Movetis
Sinclair IS Pharma
Sintetica Limited
Solvay Healthcare Ltd
Special Products Ltd
Speciality European Pharma (SEP
Spectrum Thea Pharmaceuticals Limited
SpePharm
Stanningly Pharma Limited
Steba Biotech
Stiefel Laboratories
Stirling Anglian Pharmaceuticals
Sucampo Pharmaceuticals
Sun Pharmaceuticals UK Ltd
Sunovion
Swedish Orphan
Syner-Med (PP) Ltd
Takeda UK Ltd
Targretin
Tesaro UK Ltd
Teva UK Limited
The Medicines Company
Thea Pharmaceuticals
Therabel Pharma UK Ltd
Theramex UK LTD
Thrombogenics NV
Tibotec (Janssen-Cilag Ltd)
TopoTarget A/S
Trinity Chiesi Pharmaceuticals
UCB Pharma Ltd
UK Distributer Flynn Pharma Ltd
United Therapeutics
Valeant Pharmaceuticals Ltd
Veriton Pharma
Vertex Pharmaceuticals Ltd
Vifor Pharma
ViiV Healthcare
ViiV Healthcare/GSK
Viridian Pharma Ltd (Cardinal Health)
ViroPharma Ltd
William Ransom and Son plc
Wockhardt UK Ltd
Wyeth Pharmaceuticals
Yamanouchi Pharma Ltd
Zambon SpA
From
To
Advice
Accepted
Not recommended
Restricted
Superseded
Withdrawn
Interim acceptance
Process
End of life/orphan
Ultra orphan
Additional Details
Patient Access Scheme
Advanced Search
Published
Under consideration
SMC ID
Date
Medicine
Submission Type
Indication
1290/18
15/01/2018
darunavir/cobicistat/emtricitabine/tenofovir alafenamide fumarate (Symtuza)
Abbreviated
The treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and adolescents (aged 12 years and older with body weight at least 40kg).
1081/15
10/08/2015
darunavir cobicistat (Rezolsta)
Full
In combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus-1 (HIV-1) infection in adults aged 18 years or older. Genotypic testing should guide its use.
1069/15
13/07/2015
darunavir (Prezista)
Abbreviated
Once daily darunavir co-administered with low dose ritonavir in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (HIV-1) infection in paediatric patients aged 3 to 12 years and ≥15kg who are 1) treatment-naive or 2) treatment-experienced with no darunavir resistance-associated mutations, plasma-HIV-1 RNA <100,000 copies/mL, and CD4+ count >100x106 cells/L.
948/14
10/03/2014
darunavir (Prezista)
Abbreviated
Darunavir co-administered with low dose ritonavir in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (HIV-1) infection in paediatric patients 12 to 17 years of age and at least 40kg body weight who are: antiretroviral therapy (ART) naïve; or, ART-experienced with no darunavir resistance associated mutations and who have plasma HIV-1 RNA <100,000 copies/mL and CD4+ cell count ≥100 cells/mm3.
861/13
08/04/2013
darunavir (Prezista)
Abbreviated
Human immunodeficiency virus (HIV-1) infection in adult patients as well as antiretroviral therapy (ART)-experienced paediatric patients from the age of 3 years and at least 15 kg body weight.
707/11
08/08/2011
darunavir (Prezista)
Full
For the treatment of HIV-1 infection in antiretroviral therapy (ART) experienced adults
604/10
08/02/2010
darunavir (Prezista)
Abbreviated
HIV in children and adolescents
566/09
07/09/2009
darunavir (Prezista)
Full
Human immunodeficiency virus (HIV 1) infection in antiretroviral therapy (ART) naïve adults.
530/09
10/08/2009
etravirine (Intelence)
Resubmission
HIV-1
378/07
11/06/2007
darunavir 300mg tablets (Prezista)
Full
Human immunodeficiency virus (HIV-1) infection
No medicines have been found!